proadifen has been researched along with Hemolysis in 2 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, IP | 2 |
| Yamamura, HI | 1 |
| Dixon, RL | 2 |
2 other studies available for proadifen and Hemolysis
| Article | Year |
|---|---|
The effects of beta-diethylaminoethyl-diphenylpropylacetate (SKE 525-A) on biological membranes. I. SKF 525-A-induced stabilization of human erythrocytes.
Topics: Cell Membrane; Chlorpromazine; Erythrocytes; Hemolysis; Humans; Hydrogen-Ion Concentration; Osmolar | 1968 |
Effects of beta-diethylaminoethyl-diphenylpropylacetate (SKF-525-A) on biological membranes. I. Induced stimulation of human erythrocytes.
Topics: Cell Membrane Permeability; Hemolysis; Humans; Osmotic Fragility; Proadifen; Temperature | 1968 |